1. Home
  2. AKRO vs CSW Comparison

AKRO vs CSW Comparison

Compare AKRO & CSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Akero Therapeutics Inc.

AKRO

Akero Therapeutics Inc.

HOLD

Current Price

$54.65

Market Cap

4.5B

Sector

Health Care

ML Signal

HOLD

Logo CSW Industrials Inc.

CSW

CSW Industrials Inc.

HOLD

Current Price

$305.60

Market Cap

4.4B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
AKRO
CSW
Founded
2017
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Home Furnishings
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
4.5B
4.4B
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
AKRO
CSW
Price
$54.65
$305.60
Analyst Decision
Buy
Hold
Analyst Count
11
4
Target Price
$73.56
$309.25
AVG Volume (30 Days)
2.4M
190.5K
Earning Date
11-07-2025
01-29-2026
Dividend Yield
N/A
0.35%
EPS Growth
N/A
15.78
EPS
N/A
8.52
Revenue
N/A
$964,795,000.00
Revenue This Year
N/A
$22.62
Revenue Next Year
N/A
$12.16
P/E Ratio
N/A
$35.83
Revenue Growth
N/A
14.87
52 Week Low
$21.34
$230.45
52 Week High
$58.40
$401.02

Technical Indicators

Market Signals
Indicator
AKRO
CSW
Relative Strength Index (RSI) 68.63 62.85
Support Level $54.30 $282.16
Resistance Level $54.70 $317.50
Average True Range (ATR) 0.17 11.83
MACD -0.10 -0.50
Stochastic Oscillator 71.07 58.40

Price Performance

Historical Comparison
AKRO
CSW

About AKRO Akero Therapeutics Inc.

Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.

About CSW CSW Industrials Inc.

CSW Industrials Inc is a diversified industrial growth company with well-established, scalable platforms and domain expertise across three segments, Contractor Solutions, Engineered Building Solutions, and Specialized Reliability Solutions. The company's Contractor Solutions segment involves manufacturing efficient and performance-enhancing products for residential and commercial HVAC/R and plumbing applications, which are designed for professional end-use customers. Majority of the company revenue is generated from Contractor Solutions segment from U.S. markets.

Share on Social Networks: